Oncurious Overview

  • Year Founded
  • 2015

Year Founded

  • Status
  • Private

  • Employees
  • 3

Employees

  • Latest Deal Type
  • 2ndary - Private

  • Investors
  • 2

Oncurious General Information

Description

Developer of innovative oncology treatments designed to enhance T-cell migration, infiltration, and activity into resistant tumor sites. The company's treatment focuses on clinical development activities in orphan pediatric oncology treatment, with a focus on preclinical research and drug development programs, and also works on therapies that are focused on the elimination of CCR8-expressing immune-suppressive regulatory T cells with the aim of boosting the anti-tumor immune response, enabling the healthcare industry to receive new approaches for immuno-oncology drugs targeting a broad spectrum of cancers.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Formerly VC-backed
Corporate Office
  • Gaston Geenslaan 1
  • 3001 Leuven
  • Belgium
+32 016
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Vertical(s)
Corporate Office
  • Gaston Geenslaan 1
  • 3001 Leuven
  • Belgium
+32 016

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Oncurious Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Secondary Transaction - Private 01-Dec-2025 Completed Pre-Clinical Trials
3. Grant 11-Jun-2019 Completed Pre-Clinical Trials
2. Early Stage VC 12-Dec-2017 $3.54M $3.54M Completed Pre-Clinical Trials
1. Joint Venture 14-Apr-2015 Completed Pre-Clinical Trials
To view Oncurious’s complete valuation and funding history, request access »

Oncurious Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Pref
Pref
Pref 125 $1181.55 $1181.55 1x $1181.55 2.33%
To view Oncurious’s complete cap table history, request access »

Oncurious Patents

Oncurious Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2022136647-A1 Human ccr8 binders Inactive 24-Dec-2020
WO-2022136650-A1 Murine cross-reactive human ccr8 binders Inactive 24-Dec-2020
WO-2022136649-A1 Non-blocking human ccr8 binders Inactive 24-Dec-2020
WO-2022117569-A1 A ccr8 antagonist antibody in combination with a lymphotoxin beta receptor agonist antibody in therapy against cancer Inactive 02-Dec-2020
WO-2022117572-A2 An ltbr agonist in combination therapy against cancer Inactive 02-Dec-2020 C07K16/2866
To view Oncurious’s complete patent history, request access »

Oncurious Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Oncurious Investors (2)

Investor Name Investor Type Holding Investor Since Participating Rounds
VLAIO Limited Partner
Oxurion Holding Company Majority
To view Oncurious’s complete investors history, request access »

Oncurious FAQs

  • When was Oncurious founded?

    Oncurious was founded in 2015.

  • Where is Oncurious headquartered?

    Oncurious is headquartered in Leuven, Belgium.

  • What is the size of Oncurious?

    Oncurious has 3 total employees.

  • What industry is Oncurious in?

    Oncurious’s primary industry is Drug Discovery.

  • Is Oncurious a private or public company?

    Oncurious is a Private company.

  • What is Oncurious’s current revenue?

    The current revenue for Oncurious is .

  • How much funding has Oncurious raised over time?

    Oncurious has raised $3.54M.

  • Who are Oncurious’s investors?

    VLAIO and Oxurion have invested in Oncurious.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process